Sucampo

Sucampo Pharmaceuticals, headquarted in Bethseda, Maryland, has appointed Andrew Smith, as Chief Financial Officer. Smith previously served as Sucampo's Vice President of Operations & Finance and three decades’ financial experience in the pharma industry.

The new CFO joined Sucampo in 2011 as Principal Accounting Officer. Prior to this, he was Finance Director and Company Secretary for Retroscreen Virology Ltd., a contract virology company carrying out clinical and preclinical trials on influenza vaccines. He also served as Finance Director and Company Secretary of Clearlab Europe, a division of 1-800 Contacts Inc., following its acquisition of contact lens developer VisionTec CL.

Smith has previously held senior financial management positions at Biocompatibles plc, Hydron Ltd (acquired by Biocompatibles) and Allergan.

Outside the US, Sucampo has operations in Japan, Switzerland and the UK.

(Image: Damlan Gadal)